These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17073130)

  • 1. [Limited impact of the harm-reduction policy on HCV among drug-users. The ANRS-Coquelicot survey example].
    Jauffret-Roustide M; Emmanuelli J; Desenclos JC
    Rev Epidemiol Sante Publique; 2006 Jul; 54 Spec No 1():1S53-1S59. PubMed ID: 17073130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a harm-reduction policy on HIV and hepatitis C virus transmission among drug users: recent French data--the ANRS-Coquelicot Study.
    Jauffret-Roustide M; Emmanuelli J; Quaglia M; Barin F; Arduin P; Laporte A; Desenclos JC
    Subst Use Misuse; 2006; 41(10-12):1603-21. PubMed ID: 17002994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.
    Weill-Barillet L; Pillonel J; Semaille C; Léon L; Le Strat Y; Pascal X; Barin F; Jauffret-Roustide M
    Rev Epidemiol Sante Publique; 2016 Sep; 64(4):301-12. PubMed ID: 26904917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survey of prevalence of HIV infection, syphilis and HCV infection and related risk behaviors among club drug users in Zhejiang, 2011].
    Pan X; Jiang J; He H; Chen L; Yang J; Zhang H; Wang N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Sep; 36(9):934-40. PubMed ID: 26814857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
    Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
    Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico.
    Abadie R; Welch-Lazoritz M; Gelpi-Acosta C; Reyes JC; Dombrowski K
    Harm Reduct J; 2016 Mar; 13():10. PubMed ID: 26956029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis B and C and HIV infections among problem drug users in Luxembourg: self-report versus serological evidence.
    Origer A; Schmit JC
    J Epidemiol Community Health; 2012 Jan; 66(1):64-8. PubMed ID: 20889592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and hepatitis C virus co-infection among men who have sex with men in Sydney, and associations with sexual and drug use practices.
    Lea T; Lee E; Mao L; de Wit J; Holt M
    Sex Health; 2013 Nov; 10(5):448-51. PubMed ID: 23849088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of HIV, HCV, and High-Risk Behaviors for Substance Users in Drop in Centers in Southern Iran.
    Salehi A; Naghshvarian M; Marzban M; Bagheri Lankarani K
    J Addict Med; 2015; 9(3):181-7. PubMed ID: 25748560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
    Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The investigation of HIV and HCV infection and risk factors among opiate drug users in Beijing, China.
    Bao YP; Du C; Lu HY; Lian Z; Qiu Y; Mu Y; Yan SY; Liu ZM
    Am J Drug Alcohol Abuse; 2012 Mar; 38(2):140-5. PubMed ID: 22175771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing HIV, Syphilis, and Hepatitis C Infection After a Decade of Harm Reduction Implementation Among Drug Users in Southwestern Areas of China.
    Chen Y; Tang Z; Tang S; Shen Z; Zhu Q; Li R; Huang W; Huang Y; Liang F; Wang L; Chen H; Ruan Y; Shao Y; Tsuei SH; Lan G
    J Stud Alcohol Drugs; 2018 Mar; 79(2):248-257. PubMed ID: 29553354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
    Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
    Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk behaviors for HCV- and HIV-seroprevalence among female crack users in Porto Alegre, Brazil.
    von Diemen L; De Boni R; Kessler F; Benzano D; Pechansky F
    Arch Womens Ment Health; 2010 Jun; 13(3):185-91. PubMed ID: 19760050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and HCV testing for young drug users in Rhode Island.
    Pugatch D; Anderson BJ; O'Connell JV; Elson LC; Stein MD
    J Adolesc Health; 2006 Mar; 38(3):302-4. PubMed ID: 16488833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.
    Rhodes T; Platt L; Maximova S; Koshkina E; Latishevskaya N; Hickman M; Renton A; Bobrova N; McDonald T; Parry JV
    Addiction; 2006 Feb; 101(2):252-66. PubMed ID: 16445554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.